[Latest] Global Pharmaceutical Membrane Filtration Market Size/Share Worth USD 27,620 Million by 2033 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 21, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pharmaceutical Membrane Filtration Market Size, Trends and Insights By Product...
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
February 25, 2024 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Feb. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Danaher Corporation (NYSE:...
Single-use Bioprocessing Probes and Sensors Market Size & Share to Exceed USD 6.8 Billion by 2034, at CAGR of 5.50%. Overview, Analysis, Dynamics, Report, Trend/Opportunities, Segmentation, Players, Growth Rate/Value – By Prophecy Market In
February 01, 2024 08:00 ET
|
PMI
Covina, Feb. 01, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Single-use Bioprocessing Probes and Sensors Market size was valued at about USD 4.2 Billion in 2024 and...
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
January 29, 2024 02:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Danaher Corporation (NYSE:...
Single-use Bioprocessing Probes and Sensors Market Set to Surge with Rising Demand for Biopharmaceuticals – By PMI
November 02, 2023 13:30 ET
|
PMI
Covina, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Single-use Bioprocessing Probes and Sensors Market are critical elements in the field of bioprocessing and biological production. These sensors and probes...
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign
November 01, 2023 07:00 ET
|
Jonathan Milner
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign CAMBRIDGE, England, 1 November 2023 - Jonathan Milner, the founder and one of the largest investors in Abcam plc...
Jonathan Milner Issues Statement Responding to the Glass Lewis Report
October 23, 2023 02:00 ET
|
Jonathan Milner
Jonathan Milner Issues Statement Responding to the Glass Lewis Report Welcomes the Glass Lewis report's observations on the disproportionate rewards for Abcam’s Executive Directors and on the...
Next-Generation Biomanufacturing Market Shows Impressive 7.8% CAGR and US$ 40.9 billion by 2032 in Market Growth – By PMI
October 10, 2023 12:00 ET
|
PMI
Covina, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Biopharmaceutical products are made from living cells and thus, behaves differently as compared to traditional pharmaceutical products. Next-Generation...
Jonathan Milner issues Open Letter to shareholders of Abcam plc
September 28, 2023 02:00 ET
|
Jonathan Milner
Jonathan Milner issues Open Letter to shareholders of Abcam plc Urges shareholders to Vote AGAINST the proposed acquisition of Abcam by Danaher Corporation CAMBRIDGE, England, 28 September 2023...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Danaher, Sea, and Syneos and Encourages Investors to Contact the Firm
September 12, 2023 02:30 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...